39.86
price down icon0.85%   -0.34
 
loading
前日終値:
$40.20
開ける:
$40.2
24時間の取引高:
1.64M
Relative Volume:
0.69
時価総額:
$4.54B
収益:
$264.79M
当期純損益:
$-14.36M
株価収益率:
-362.36
EPS:
-0.11
ネットキャッシュフロー:
$-28.11M
1週間 パフォーマンス:
-7.28%
1か月 パフォーマンス:
+39.71%
6か月 パフォーマンス:
+67.27%
1年 パフォーマンス:
+162.06%
1日の値動き範囲:
Value
$38.78
$40.56
1週間の範囲:
Value
$38.78
$43.32
52週間の値動き範囲:
Value
$12.93
$43.32

Tg Therapeutics Inc Stock (TGTX) Company Profile

Name
名前
Tg Therapeutics Inc
Name
セクター
Healthcare (1166)
Name
電話
(212) 554-4484
Name
住所
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Name
職員
0
Name
Twitter
@TGTherapeutics
Name
次回の収益日
2025-03-03
Name
最新のSEC提出書
Name
TGTX's Discussions on Twitter

TGTX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
TGTX
Tg Therapeutics Inc
39.86 4.54B 264.79M -14.36M -28.11M -0.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
492.69 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
637.36 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
589.15 35.93B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
268.46 34.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
267.39 28.24B 3.81B -644.79M -669.77M -6.24

Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-29 開始されました TD Cowen Buy
2023-08-02 アップグレード Goldman Sell → Neutral
2023-06-26 再開されました Jefferies Buy
2022-05-20 開始されました BofA Securities Underperform
2022-02-23 繰り返されました B. Riley Securities Buy
2021-11-15 ダウングレード Goldman Neutral → Sell
2021-04-20 開始されました Goldman Neutral
2021-04-19 繰り返されました H.C. Wainwright Buy
2020-09-01 開始されました JP Morgan Overweight
2020-08-11 繰り返されました H.C. Wainwright Buy
2020-06-05 開始されました Evercore ISI Outperform
2020-01-17 繰り返されました H.C. Wainwright Buy
2019-11-27 再開されました B. Riley FBR Buy
2019-02-06 再開されました Jefferies Buy
2018-09-25 ダウングレード Raymond James Strong Buy → Outperform
2018-03-09 繰り返されました B. Riley FBR, Inc. Buy
2017-12-01 再開されました B. Riley FBR, Inc. Buy
2017-11-14 再開されました H.C. Wainwright Buy
2017-04-25 開始されました Jefferies Buy
2017-03-06 繰り返されました FBR & Co. Outperform
2016-10-06 再開されました Brean Capital Buy
2016-05-27 開始されました SunTrust Buy
2015-12-01 開始されました FBR Capital Outperform
2015-09-09 開始されました Raymond James Strong Buy
2015-08-12 再開されました H.C. Wainwright Buy
2015-06-19 繰り返されました Brean Capital Buy
2014-12-11 繰り返されました ROTH Capital Buy
2014-12-10 繰り返されました ROTH Capital Buy
すべてを表示

Tg Therapeutics Inc (TGTX) 最新ニュース

pulisher
Mar 25, 2025

Strength Seen in TG Therapeutics (TGTX): Can Its 10.2% Jump Turn into More Strength? - MSN

Mar 25, 2025
pulisher
Mar 25, 2025

Based On Its ROE, Is TG Therapeutics, Inc. (NASDAQ:TGTX) A High Quality Stock? - Simply Wall St

Mar 25, 2025
pulisher
Mar 23, 2025

(TGTX) Investment Analysis and Advice - Stock Traders Daily

Mar 23, 2025
pulisher
Mar 21, 2025

TG Therapeutics stock soars to 52-week high of $43.03 By Investing.com - Investing.com South Africa

Mar 21, 2025
pulisher
Mar 21, 2025

TG Therapeutics stock soars to 52-week high of $43.03 - Investing.com India

Mar 21, 2025
pulisher
Mar 21, 2025

TG Therapeutics (TGTX) technical analysisTG Therapeutics (NASDAQ:TGTX) - Benzinga

Mar 21, 2025
pulisher
Mar 19, 2025

TG Therapeutics (TGTX): Among the Best Short Squeeze Stocks to Buy According to Analysts - Yahoo Finance

Mar 19, 2025
pulisher
Mar 17, 2025

Multiple Sclerosis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Medication, Epidemiology, Prevalence, Therapies and Companies by DelveInsight - The Globe and Mail

Mar 17, 2025
pulisher
Mar 15, 2025

Precision & TG Therapeutics: Unlocking Value With ARCUS, BRIUMVI And Azer-Cel (NASDAQ:DTIL) - Seeking Alpha

Mar 15, 2025
pulisher
Mar 15, 2025

TG Therapeutics stock soars to 52-week high of $40.32 By Investing.com - Investing.com Australia

Mar 15, 2025
pulisher
Mar 14, 2025

TG Therapeutics: Bright Outlook, Bolstered By Briumvi And Upcoming Trials (NASDAQ:TGTX) - Seeking Alpha

Mar 14, 2025
pulisher
Mar 14, 2025

TG Therapeutics stock soars to 52-week high of $40.32 - Investing.com India

Mar 14, 2025
pulisher
Mar 14, 2025

TG Therapeutics Stock (TGTX): Advancing MS Treatment - Value the Markets

Mar 14, 2025
pulisher
Mar 14, 2025

Is TG Therapeutics, Inc. (TGTX) the Best Performing Growth Stock in 2025? - Insider Monkey

Mar 14, 2025
pulisher
Mar 13, 2025

(TGTX) Technical Data - Stock Traders Daily

Mar 13, 2025
pulisher
Mar 12, 2025

TG Therapeutics: Exciting Briumvi Performance, Looking To Re-Enter (NASDAQ:TGTX) - Seeking Alpha

Mar 12, 2025
pulisher
Mar 12, 2025

10 Best Performing Growth Stocks in 2025 - Insider Monkey

Mar 12, 2025
pulisher
Mar 12, 2025

Proficio Capital Partners LLC Buys Shares of 10,174 TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

TG Therapeutics call volume above normal and directionally bullish - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Smartleaf Asset Management LLC Has $60,000 Stock Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

Mar 11, 2025
pulisher
Mar 09, 2025

TG Therapeutics (NasdaqCM:TGTX) Surges 28% Following US$23 Million Net Income Turnaround - Yahoo Finance

Mar 09, 2025
pulisher
Mar 09, 2025

Bilibili, MARA And ZEEKR Are Among Top 8 Mid-Cap Gainers Last Week (Mar 3-Mar 7): Are The Others In Your Portfolio? - Benzinga

Mar 09, 2025
pulisher
Mar 09, 2025

Bank of New York Mellon Corp Increases Stake in TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World

Mar 09, 2025
pulisher
Mar 08, 2025

Q2 Earnings Forecast for TG Therapeutics Issued By B. Riley - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Why TG Therapeutics Stock Was Soaring This Week - MSN

Mar 08, 2025
pulisher
Mar 07, 2025

TGTX Surges on Strong Q4 Results and Briumvi Success - GuruFocus.com

Mar 07, 2025
pulisher
Mar 07, 2025

Why TG Therapeutics Shares Are Soaring Now - TipRanks

Mar 07, 2025
pulisher
Mar 07, 2025

Retail Bets TG Therapeutics Stock Can Sustain Post-Earnings Gains Throughout The Week - MSN

Mar 07, 2025
pulisher
Mar 07, 2025

TG Therapeutics Announces Schedule of Data Presentations - GlobeNewswire

Mar 07, 2025
pulisher
Mar 07, 2025

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting - Yahoo Finance

Mar 07, 2025
pulisher
Mar 07, 2025

Q1 Earnings Forecast for TG Therapeutics Issued By B. Riley - Defense World

Mar 07, 2025
pulisher
Mar 06, 2025

This Biotech Stock Hits Buy Point After Earnings Burst - MSN

Mar 06, 2025
pulisher
Mar 06, 2025

HC Wainwright Reaffirms “Buy” Rating for TG Therapeutics (NASDAQ:TGTX) - Defense World

Mar 06, 2025
pulisher
Mar 06, 2025

TG Therapeutics FY2025 EPS Estimate Boosted by HC Wainwright - Defense World

Mar 06, 2025
pulisher
Mar 05, 2025

Why TG Therapeutics, Inc. (TGTX) Surged On Monday? - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

TG Therapeutics, Inc. (NASDAQ:TGTX) Holdings Decreased by Private Advisor Group LLC - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

TG Therapeutics (NASDAQ:TGTX) Upgraded by StockNews.com to Hold Rating - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

TG Therapeutics (NASDAQ:TGTX) Shares Up 5.2% After Earnings Beat - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

TG Therapeutics, Inc. (NASDAQ:TGTX) Q4 2024 Earnings Call Transcript - MSN

Mar 05, 2025
pulisher
Mar 04, 2025

TG Therapeutics Target of Unusually Large Options Trading (NASDAQ:TGTX) - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

TG Therapeutics, A New Leaderboard Stock, Skyrockets 17% On Sales Beat, Bullish Guide - MSN

Mar 04, 2025
pulisher
Mar 04, 2025

TG Therapeutics stock soars to 52-week high of $36.89 By Investing.com - Investing.com South Africa

Mar 04, 2025
pulisher
Mar 04, 2025

TG Therapeutics stock soars to 52-week high of $36.89 - Investing.com India

Mar 04, 2025
pulisher
Mar 04, 2025

Cautious Outlook on TG Therapeutics Amid Competitive Pressures and Overvaluation Concerns - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

B. Riley Raises Price Target on TG Therapeutics to $53 From $38, Keeps Buy Rating -March 04, 2025 at 08:05 am EST - Marketscreener.com

Mar 04, 2025
pulisher
Mar 04, 2025

H.C. Wainwright maintains TG Therapeutics stock Buy rating, $55 target - Investing.com India

Mar 04, 2025

Tg Therapeutics Inc (TGTX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Tg Therapeutics Inc (TGTX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Power Sean A
CFO
Jan 06 '25
Sale
28.53
10,021
285,939
660,611
$77.99
price up icon 0.39%
$306.97
price down icon 0.34%
$31.37
price down icon 0.88%
$20.32
price down icon 1.36%
$94.95
price down icon 0.47%
biotechnology ONC
$267.39
price up icon 1.82%
大文字化:     |  ボリューム (24 時間):